[Treatment of thrombosis and embolism with panthesin-hydergin (PH 203)].
D062365:Aminobenzoates / Q000627:therapeutic use*; D004088:Dihydroergotoxine; D004338:Drug Combinations; D004617:Embolism / Q000628:therapy*; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D007930:Leucine / Q000031:analogs & derivatives; D011343:Procaine / Q000031:analogs & derivatives; D013927:Thrombosis / Q000628:therapy*; D062366:para-Aminobenzoates
D062365:Aminobenzoates; D004338:Drug Combinations; D004876:Ergot Alkaloids; C006783:dihydroergotoxin, p-aminobenzoyl-N-diethyl-leucinol drug combination; D062366:para-Aminobenzoates; D004088:Dihydroergotoxine; D011343:Procaine; C005426:leucinocaine mesylate; D007930:Leucine
AMINOBENZOATES/therapeutic use; EMBOLISM/therapy; ERGOT ALKALOIDS/therapeutic use; THROMBOSIS/therapy
Thrombose- und Emboliebehandlung mit Panthesin-Hydergin (PH 203).